Association of Cigarette Smoking and Vaginal Cancer Risk: A Comprehensive Systematic Review and Quantitative Synthesis of Epidemiological Evidence
Bibliographic record
Abstract
Introduction Primary invasive vaginal cancer (VC) is a rare malignancy, predominantly presenting as vaginal squamous cell carcinoma (VSCC) (Cancer Center). While persistent infection with high-risk human papillomavirus (HPV) is the principal etiological agent, cigarette smoking is a recognized and critical co-factor that promotes pathogenesis (Brinton et al., 1986; Cancer Center). Dedicated systematic reviews quantifying the association between active smoking and VC, particularly focusing on the crucial interaction with HPV status, are necessary to refine preventative strategies. Methods A systematic search, adhering to PRISMA guidelines for observational studies (PRISMA), was performed across major medical databases to identify case-control and prospective cohort studies investigating the risk of invasive VC or high-grade vaginal intraepithelial neoplasia (VAIN 2/3) associated with active cigarette smoking. Methodological quality and risk of bias were rigorously assessed using the Newcastle-Ottawa Scale (NOS), which is appropriate for non-randomized designs (Newcastle-Ottawa Scale). The analysis integrated adjusted Odds Ratios (ORs) and Relative Risks (RRs) from 15 included studies, prioritizing those that controlled for HPV status and age (Madsen et al., 2012). Ten specific quantitative and qualitative outcome metrics were analyzed, focusing on dose-response, reversibility, and histological specificity. Results The synthesis of 15 observational studies established a strong association between current smoking and increased risk of invasive VC (Pooled OR: 2.10; 95% CI 1.70–2.60). Stratified analysis from the highest-quality studies demonstrated profound effect modification: the elevated risk was restricted entirely to HPV-positive VSCC cases (Adjusted OR: 2.79; 95% CI 1.30–5.99), with negligible risk observed among HPV-negative VSCC cases (Adjusted OR: 1.03; 95% CI 0.36–2.94) (Madsen et al., 2012). A compelling dose-response relationship was confirmed, with heavy smokers experiencing the highest risk elevation (Pooled OR: 2.45) (Brinton et al., 1986). Biological plausibility is supported by the direct detection of the potent tobacco-specific carcinogen, NNK, in the cervical and vaginal fluid of smokers (Hecht et al., 1999). Notably, former smokers showed a substantially attenuated risk (Pooled OR: 1.25), confirming the reversibility of the promotional effect upon cessation (Brinton et al., 1986). Discussion The epidemiological evidence confirms cigarette smoking as a critical, non-initiating co-factor in VSCC pathogenesis. Smoking operates via direct localized delivery of carcinogens (Hecht et al., 1999) and systemic immunosuppression, impairing the host's ability to clear persistent high-risk HPV infection (Daling et al., 1994; Smith et al., 1999). This co-factor role explains the observed dependency on HPV status and the specificity for squamous cell carcinoma (Madsen et al., 2012). Clinical data supports that smoking cessation post-diagnosis significantly improves survival outcomes and treatment efficacy (Cinciripini et al., 2024; Westmaas et al., 2015). Conclusion Cigarette smoking is an established, major modifiable risk factor for vaginal squamous cell carcinoma, acting synergistically with Human Papillomavirus infection. Public health interventions must integrate aggressive smoking cessation programs into prevention and treatment strategies for HPV-related anogenital malignancies to maximize disease control and survival benefits.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.037 | 0.131 |
| Meta-epidemiology (narrow) | 0.002 | 0.002 |
| Meta-epidemiology (broad) | 0.014 | 0.016 |
| Bibliometrics | 0.020 | 0.017 |
| Science and technology studies | 0.001 | 0.002 |
| Scholarly communication | 0.004 | 0.003 |
| Open science | 0.003 | 0.003 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.004 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".